Kaleido Biosciences (KLDO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends KLDO vs. ELYS, GROM, KBNT, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, ARRWW, and AUROWShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Elys BMG Group (ELYS), Grom Social Enterprises (GROM), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), Arrowroot Acquisition (ARRWW), and Aurora Innovation (AUROW). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Elys BMG Group Grom Social Enterprises Kubient Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Arogo Capital Acquisition Arrowroot Acquisition Aurora Innovation Elys BMG Group (NASDAQ:ELYS) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk. Does the media prefer ELYS or KLDO? In the previous week, Elys BMG Group's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score. Company Overall Sentiment Elys BMG Group Neutral Kaleido Biosciences Neutral Does the MarketBeat Community prefer ELYS or KLDO? Kaleido Biosciences received 36 more outperform votes than Elys BMG Group when rated by MarketBeat users. However, 75.00% of users gave Elys BMG Group an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformElys BMG GroupOutperform Votes1875.00% Underperform Votes625.00% Kaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% Do institutionals & insiders have more ownership in ELYS or KLDO? 81.6% of Kaleido Biosciences shares are owned by institutional investors. 18.5% of Elys BMG Group shares are owned by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, ELYS or KLDO? Elys BMG Group has higher revenue and earnings than Kaleido Biosciences. Elys BMG Group is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElys BMG Group$43.86M0.00-$18.26M-$0.560.00Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A Which has more risk & volatility, ELYS or KLDO? Elys BMG Group has a beta of 2.63, indicating that its stock price is 163% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Is ELYS or KLDO more profitable? Company Net Margins Return on Equity Return on Assets Elys BMG GroupN/A N/A N/A Kaleido Biosciences N/A N/A N/A SummaryElys BMG Group beats Kaleido Biosciences on 6 of the 9 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$4,000.00$165.68M$5.14B$9.08BDividend YieldN/A3.64%5.09%4.23%P/E Ratio0.00115.5190.0517.20Price / SalesN/A18,531.021,117.09117.04Price / CashN/A12.8743.1037.85Price / BookN/A8.594.784.78Net Income-$95.48M-$20.67M$120.31M$225.60M Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/AN/AN/AN/A$4,000.00$1.10M0.0076Positive NewsGap UpELYSElys BMG GroupN/A$0.00flatN/A-99.8%$16,000.00$43.86M0.0090GROMGrom Social EnterprisesN/A$0.00flatN/A-100.0%$4,000.00$3.72M0.00450KBNTKubientN/A$0.00+200.0%N/A-95.0%$4,000.00$1.17M0.0040Gap UpALFIWAlfiN/A$0.04-21.0%N/AN/A$0.00$200,684.000.0040Gap DownHigh Trading VolumeAPCXWAppTech PaymentsN/A$0.16-5.2%N/A-53.6%$0.00$365,000.000.0018News CoveragePositive NewsGap DownARBEWArbe RoboticsN/A$0.14+1.8%N/A-17.6%$0.00$1.02M0.00120High Trading VolumeAOGOWArogo Capital AcquisitionN/A$0.01-82.7%N/AN/A$0.00N/A0.00N/AAOGOUArogo Capital AcquisitionN/A$8.50-22.5%N/AN/A$0.00N/A0.00N/AARRWWArrowroot AcquisitionN/A$0.06flatN/A-14.4%$0.00N/A0.0098Gap UpAUROWAurora InnovationN/A$1.56+17.3%N/A+181.8%$0.00$2M0.001,700News Coverage Related Companies and Tools Related Companies Elys BMG Group Competitors Grom Social Enterprises Competitors Kubient Competitors Alfi Competitors AppTech Payments Competitors Arbe Robotics Competitors Arogo Capital Acquisition Competitors Arogo Capital Acquisition Competitors Arrowroot Acquisition Competitors Aurora Innovation Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KLDO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLDO Stock Alerts